Mediobanca Analyst Coverage, 1 agosto 2018
Giuseppe Grimaldi
Alessandro Tortora
Mediobanca
Last Research:
1 agosto 2018 (Coverage update based on IH18 Results)
Target Price: 0,60€
Recommendation: Neutral
Document
mediobanca_molmed_2018-08-01_ih18.pdf
Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.
